Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikram Sinha

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2016
Role of Quantitative Clinical Pharmacology in Pediatric Approval and LabelingNitin Mehrotra, Atul Bhattaram, Justin C Earp, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28-29, 2014Martin Offringa, Jonathan M Davis, Mark A Turner, et al.
Clinical Pharmacology and Therapeutics|January 4, 2020
Hippocampal Neuroimaging-Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open DataDaniela J Conrado, Jackson Burton, Derek Hill, et al.
Orphanet Journal of Rare Diseases|February 10, 2019
Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholdersAndrew E Mulberg, Christina Bucci-Rechtweg, Joseph Giuliano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancerMichael A Carducci, Luna Musib, Merrill S Kies, et al.
Clinical and Translational Science|July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling AnalysisDaniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.
Clinical and Translational Science|February 2, 2019
Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseKlaus Romero, Daniela Conrado, Jackson Burton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2018
Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic ClearanceDavid C Turner, Anna G Kondic, Keaven M Anderson, et al.
Journal of Clinical Pharmacology|January 23, 2020
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and VomitingJeremiah D Momper, M Tobias Heinrichs, Kevin Krudys, et al.
Clinical Pharmacology and Therapeutics|March 23, 2024
Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting ProgramGerald R Galluppi, Malidi Ahamadi, Souvik Bhattacharya, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2016
Role of Quantitative Clinical Pharmacology in Pediatric Approval and LabelingNitin Mehrotra, Atul Bhattaram, Justin C Earp, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28-29, 2014Martin Offringa, Jonathan M Davis, Mark A Turner, et al.
Clinical Pharmacology and Therapeutics|January 4, 2020
Hippocampal Neuroimaging-Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open DataDaniela J Conrado, Jackson Burton, Derek Hill, et al.
Orphanet Journal of Rare Diseases|February 10, 2019
Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholdersAndrew E Mulberg, Christina Bucci-Rechtweg, Joseph Giuliano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancerMichael A Carducci, Luna Musib, Merrill S Kies, et al.
Clinical and Translational Science|July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling AnalysisDaniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.
Clinical and Translational Science|February 2, 2019
Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseKlaus Romero, Daniela Conrado, Jackson Burton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2018
Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic ClearanceDavid C Turner, Anna G Kondic, Keaven M Anderson, et al.
Journal of Clinical Pharmacology|January 23, 2020
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and VomitingJeremiah D Momper, M Tobias Heinrichs, Kevin Krudys, et al.
Clinical Pharmacology and Therapeutics|March 23, 2024
Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting ProgramGerald R Galluppi, Malidi Ahamadi, Souvik Bhattacharya, et al.
Pageof 5